ConductScience.org, home
Cell lines
API referenceFor AI assistants

Cell line · CVCL_1267

HCC38

Cancer cell line, Homo sapiens. Breast ductal carcinoma. 67 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. HCC38. Cell lines, record CVCL_1267. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1267

On this page

Cell line

As Cellosaurus gives it.

Name
HCC38
Accession
CVCL_1267
RRID
RRID:CVCL_1267
Synonyms
Hcc38, HCC-38, HCC 38, HCC0038, Hamon Cancer Center 38
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
50Y
Category
Cancer cell line
Diseases
Breast ductal carcinoma (NCIt C4017)
Derived from
Breast (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers67

PaperJournalYearHow we knowRetractedSource
The role of autoproteolysis and mitoribosomal proteins in the regulation of the mitochondrial LACTB tumor suppressor.EMBO Rep2026Its Methods give the RRID and name the linePubMed
HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer.Sci Prog2026Its Methods give the RRID and name the linePubMed
Inhibition of cyclin-dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation.Mol Oncol2026Its Methods give the RRID and name the linePubMed
TSPYL5 Promotes Triple-Negative Breast Cancer Metastasis by Antagonizing USP10-Mediated PTEN Stabilization to Unleash a ZEB1-Dependent EMT Program.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC.Cancer Sci2026Its Methods give the RRID and name the linePubMed
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.Cancer Res2025Its Methods give the RRID and name the linePubMed
Hypoxia Induces Immunosuppression by Silencing STING in Cancer.Cancer Res2025Its Methods give the RRID and name the linePubMed
LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer.Mol Cancer Res2025Its Methods give the RRID and name the linePubMed
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without Lymphocytopenia.Cancer Res Commun2025Its Methods give the RRID and name the linePubMed
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers.Cancer Lett2025Cellosaurus cites itPubMed

1 to 10 of 67

See all 67 papers

Relatives7

RelationCell lineAccessionProblemSource
Derived from itHCC38/Cas9-hygCVCL_C9DDCell lines
Derived from itHCC38rCDDP3000CVCL_D6VKCell lines
Derived from itHCC38rDOX40CVCL_D6VLCell lines
Derived from itHCC38rERI10CVCL_D6VMCell lines
Derived from itHCC38rGEM20CVCL_D6VNCell lines
Derived from itHCC38rPCL2.5CVCL_D6VPCell lines
From the same personHCC38 BLCVCL_1268Cell lines

Cell banks4

Cell bankCatalog numberStatusSource
ATCCCRL-2314ATCC
CLS305307CLS
HysigenTCH-C416Hysigen
KCLB9S0038KCLB

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1267

GET https://conductscience.org/api/cell-lines/v1/CVCL_1267/papers?page=2

API referenceFor AI assistants